Calquence for Mantle Cell Lymphoma User Reviews
- Che...
- Taken for 1 to 6 months
- August 30, 2023
"So far, no major issues. I have been using it for about 4 months now, since Imbruvica was pulled for mantle cell lymphoma treatment. Bowels move a bit differently than with Imbruvica, but not enough so as to be a problem. My doctors seem to be well satisfied with the way it is working, holding the lymphoma in check if nothing else."
- sd ...
- Taken for 6 months to 1 year
- December 13, 2024
"Have severe brain fog, could not live with, had to change to zanabrutinib."
See also:
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Kesimpta
Kesimpta (ofatumumab) is used to treat relapsing forms of multiple sclerosis. Includes Kesimpta ...
Brukinsa
Brukinsa is used to treat adults with mantle cell lymphoma, Waldenström’s macroglobulinemia, ma ...
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Velcade
Velcade injection is used to treat multiple myeloma and mantle cell lymphoma. Includes Velcade side ...
Frequently asked questions
- Nan...
- Taken for 1 to 6 months
- May 14, 2024
"Minor side effects very manageable. I highly recommend trying Calquence!"
Are you taking this medicine?
Your review helps others make informed decisions.More about Calquence (acalabrutinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (34)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: BTK inhibitors
- Breastfeeding
- En español
"My latest PET scan showed that Calquence is working to reduce MCL activity. Side effects mostly occurred when I started the medication, and they were brief. These included fatigue, tinnitus in my left ear, lower appetite, and weight loss. My weight is now stable, although down about 13 pounds from when I started. But I’m okay with that, since it’s a better weight for me. I do have some rashes, which my oncologist says are due to the medication."